Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD
Top Cited Papers
- 1 May 2003
- Vol. 58 (5) , 399-404
- https://doi.org/10.1136/thorax.58.5.399
Abstract
Background: A study was undertaken to record exacerbations and health resource use in patients with COPD during 6 months of treatment with tiotropium, salmeterol, or matching placebos.Keywords
This publication has 20 references indexed in Scilit:
- Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.European Respiratory Journal, 2002
- A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2002
- Use of a Long-acting Inhaled β2-Adrenergic Agonist, Salmeterol Xinafoate, in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options.2001
- Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ, 2000
- Spirometric Correlates of Improvement in Exercise Performance after Anticholinergic Therapy in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitisJournal of Antimicrobial Chemotherapy, 1999
- A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory QuestionnaireAmerican Review of Respiratory Disease, 1992
- Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 1987
- The Measurement of DyspneaChest, 1984